These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 1475920)
21. Circulating vascular endothelial growth factor levels are decreased in patients with chronic hepatitis and liver cirrhosis depending on the degree of hepatic damage. Desideri G; Ferri C Clin Sci (Lond); 2000 Aug; 99(2):159-60. PubMed ID: 10918050 [No Abstract] [Full Text] [Related]
22. Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies. Kage M; Shimamatu K; Nakashima E; Kojiro M; Inoue O; Yano M Hepatology; 1997 Apr; 25(4):1028-31. PubMed ID: 9096615 [TBL] [Abstract][Full Text] [Related]
23. [Rapid development of liver cirrhosis following acute non-A, non-B hepatitis]. Huth M; Liehr H; Spech HJ Z Gastroenterol; 1989 May; 27(5):272-8. PubMed ID: 2502883 [TBL] [Abstract][Full Text] [Related]
26. [Correlations between laboratory and ultrasonic diagnosis and needle biopsy in chronic hepatitis and alcoholic cirrhosis]. Pace M; Dotta C; Moretto F; Breda A; Rizzo A; Sanzuol F Minerva Med; 1990; 81(1-2):27-44. PubMed ID: 2179768 [TBL] [Abstract][Full Text] [Related]
27. [Knodell and Metavir scoring systems--advantages and limits]. Stanciu A; Floarea-Strat A Rev Med Chir Soc Med Nat Iasi; 2002; 106(4):753-6. PubMed ID: 14974223 [TBL] [Abstract][Full Text] [Related]
28. [The clinical manifestations and the plasma levels of fibronectin and fibrin-fibrinogen degradation products in different morphological forms of chronic hepatitis]. Malaia LT; Iabluchanskiĭ NI; Panchuk SN; Babak OIa Ter Arkh; 1991; 63(11):44-6. PubMed ID: 1810062 [TBL] [Abstract][Full Text] [Related]
29. [Hepatitis delta virus infection: an immunohistochemical study]. Preisegger KH; Denk H Wien Klin Wochenschr; 1989 Sep; 101(16):544-7. PubMed ID: 2678760 [TBL] [Abstract][Full Text] [Related]
31. [Is liver biopsy the gold standard for assessment of liver fibrosis?]. Hu XQ Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):568-70. PubMed ID: 23227530 [No Abstract] [Full Text] [Related]
32. [Comparison of pre- and post-treatmental hepatohistology with heavy dosage of Paeonia rubra on chronic active hepatitis caused liver fibrosis]. Yang DG Zhongguo Zhong Xi Yi Jie He Za Zhi; 1994 Apr; 14(4):207-9, 195. PubMed ID: 7950194 [TBL] [Abstract][Full Text] [Related]
33. [Value of puncture biopsy of the liver during diagnostic and follow-up examinations (clinical aspects, immunological markers, images) in chronic hepatitis]. Gonvers JJ Schweiz Med Wochenschr; 1986 Aug; 116(31-32):1030-5. PubMed ID: 2428101 [TBL] [Abstract][Full Text] [Related]
34. Variability in the morphological spectrum and clinical outcome of chronic liver disease in hepatitis B-positive and B-negative renal transplant recipients. Rao KV; Kasiske BL; Anderson WR Transplantation; 1991 Feb; 51(2):391-6. PubMed ID: 1994533 [TBL] [Abstract][Full Text] [Related]
35. Natural course of chronic hepatitis C. Takahashi M; Yamada G; Miyamoto R; Doi T; Endo H; Tsuji T Am J Gastroenterol; 1993 Feb; 88(2):240-3. PubMed ID: 8424428 [TBL] [Abstract][Full Text] [Related]
36. Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis. Kanki A; Tamada T; Higaki A; Noda Y; Tanimoto D; Sato T; Higashi H; Ito K Magn Reson Imaging; 2012 Apr; 30(3):356-60. PubMed ID: 22227353 [TBL] [Abstract][Full Text] [Related]